Covid-19 Vaccine Roll-out Debate
Full Debate: Read Full DebateMark Harper
Main Page: Mark Harper (Conservative - Forest of Dean)Department Debates - View all Mark Harper's debates with the Department of Health and Social Care
(4 years ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Of course I will defend to the end the work that we did to get the PPE roll-out to which the hon. Lady refers. Of course we had priority contracts, because we wanted, when somebody had a good lead, to be able to see if we could make an arrangement as fast as possible, but that was all done through the proper processes, as the NAO report sets out. She asks—I have a lot of respect for the hon. Lady, but really—whether private companies will be involved in the vaccine roll-out. Try Pfizer or BioNTech, the people who came up with and are manufacturing this vaccine. Without them, we would not have a vaccine at all, and a bit of a thank you would do well from the Chair of the Public Accounts Committee.
I join the Secretary of State in thanking the NHS staff in my Gloucestershire Hospitals NHS Foundation Trust who are in the first 50 hospitals to be rolling out the vaccine. That is very welcome, including to my constituents. Given that he was right to be a little cautious about the speed at which we will be able to get this vaccine rolled out, it seems to me not right that we should keep every single restriction in place until we have rolled out the vaccine to the entire population. The onus still remains on the Government to justify every restriction and the balance between the benefits of reducing covid, the economic impact and the non-covid health harm. May I ask the Government to set out that detail before the House is asked to take another decision on these restrictions in January?
The House might be relieved to know that my right hon. Friend and I agree with each other on the need to ensure that, as the vaccine is rolled out to vulnerable groups, we monitor the impact of the vaccine on reducing cases, reducing hospitalisations and reducing the number of people who sadly die from this disease, and take that basis for the judgment of how soon we can lift the restrictions. He and I want to lift the restrictions as soon as is safely possible, and the question of the judgment on how safely is one that we will have to monitor and debate in this House over the coming weeks and months.